Infantile hemangiomas (IHs) are the most common soft-tissue tumor of infancy, with a prevalence of 4.5%.1 They appear shortly after birth, grow to peak size by about 9 months of age, and then involute over months to years. Up to 70% of the time when left untreated, the process of vascular degeneration results in permanent sequelae such as telangiectasia, anetoderma, and/or excess fibrofatty tissue, all of which can cause significant cosmetic or functional concerns.1 Treatment of fibrofatty residua (FFR) is primarily surgical, with laser, liposuction, and nonablative fractional photothermolysis representing other options.2-4 We report the first case to our knowledge of FFR successfully treated with intralesional deoxycholic acid (DCA).
Cardis MA, DeKlotz CMC. Intralesional Deoxycholic Acid Treatment for Fibrofatty Residua of Involuted Infantile Hemangiomas: A Novel Therapeutic Approach. JAMA Dermatol. 2018;154(6):735–737. doi:10.1001/jamadermatol.2018.0617
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.